Čeština
|
Dansk
|
Deutsch
|
English
|
Español
|
Français
|
Italiano
|
Nederlands
|
Norsk
|
Polski
|
Português
|
Pусский
|
Suomi
|
Svenska
|
US
EHDN2016
KRANKHEITSBILD
NETZWERK
REGISTRY
PROJEKTE
ANMELDEN
Imaging
-
Aktuelles
Das Projekt
Sponsor
Vorstand
Arnesen
Blumenstein
Burgunder
Craufurd
Humbert
Jones
Kremer
Reilmann
Roos
Rosser
Weydt
Capper-Loup
Feihle
Levey
McLean
Öffentliche Dokumente
Writing Committee Strategic ...
Wissenschaftl. Begutachtung
Zentrale Koordination
Länderkoordination
Fellowship Programme
Constitution
Article 1
Article 2
Article 3
Article 4
Article 5
Article 6
Article 7
Article 8
Article 9
Article 10
Article 11
Article 12
Documents
Voting/Nomination
Mitglieder
Standorte
Arbeitsgruppen
Advanced HD
Dates
Meetings
Psychiatrischer Phänotyp
Dates
Meetings
Meeting 2005/06
Meeting 2005/09
Meeting 2008/09
Meeting 2009/03
Meeting 2010/03
Meeting 2011/05
Psycho appr. & interv. Sub...
Biologische Modifizierer
Termine
Meetings
Biomarker
Hirngewebedatenbank
Kognitiver Phänotyp
Termine
Treffen
Environmental Modifiers
Funktionelle Fähigkeit
Termine
Treffen
Genetische Tests/Beratung
Modifizierende Gene
Termine
Meetings
Gesundheitsökonomie
Bildgebende Verfahren
Juvenile HK
Termine
Motorischer Phänotyp
Neuroprotektive Therapie
Physiotherapie
Termine
Meetings
Lebensqualität
Termine
Treffen
Behandlungstandards
Termine
Meetings
Dieticians
SALT
Dental care
Occupational
Chirurgische Ansätze
Symptomatische Therapie
Young Adults
Veranstaltungen
EHDN 2016
Announcement
Introduction
Registration
Programme Fri
Programme Sat
Programme Sun
Additional Meetings
Floor plan
Overduin Registration
CME points
Sponsoring
Travel Information
Hotel booking
Social activities
Reimbursement
Abstract Submission
Contacts
Documents
Feedback
EHDN 2014
EHDN 2012
Introduction
Announcement
Programme Fri
Programme Sat
Programme Sun
Additional Meetings
Important Dates
Registration
Travel & Accommodation
EHA Registration
EHA Programme
Reception Dinner
About Stockholm
Abstract Submission
Reimbursement
Documents
Handouts
Presentations
Posters
Pathogenic mechanisms
Animal models
Choreatic disorders - no...
Genetic modifiers
Wet Biomarkers
Imaging
Clin characteristics
Clin char-motor
Clin char-cognitive
Clin char - behaviour
Clin char-other
Clinical studies
Genetic testing
Clinical care
Experimental Rx
Clinical Rx
Non-scientific
Contacts
Feedback & Evaluation
EHDN 2010
Introduction
Programme I
Programme II
Additional Meetings
Registration
EHA Programme
EHA Registration
Plenary Dinner
Social Programme
Important Dates
Abstract Submission
Reimbursement
Hotel Booking
Travel and Location
About Prague
Documents
Committees
Contact
Feedback & Evaluation
EHDN 2008
EHDN 2007
EHDN 2006
Einführung
Programm
Galadiner
Tagungsort
Über Blankenberge
EHDN 2005
EHDN 2004
Kommunikation
Stellenangebote
Datum
Beschreibung
Größe
Autor
Dokument
04.08.26
Alterations in iron content in the brain of Huntington Disease mutation carriers in comparison with healthy control subjects
32 kB
anonymous
g05-alterations-in-iron-content
04.08.26
Iron defect is implicated in white matter changes in Huntington Disease
32 kB
anonymous
g06-iron-defect
04.08.26
Reliability of diffusion tensor imaging measures
32 kB
anonymous
g07-diffusion-tensor-imaging-measures
04.08.26
Brain Structure in Children at Risk for Huntington’s Disease
32 kB
anonymous
g04-brain-structure-in-children-at-risk
04.08.26
Corpus callosal atrophy in Huntington’s Disease
32 kB
anonymous
g03-corpus-callosal-atrophy
04.08.26
Evaluation of multi-modal, multi-site imaging measures in Huntington’s Disease: baseline results from the Paddington study
32 kB
anonymous
g01-imaging-measures-paddington
04.08.26
Brain structure in preclinical Huntington’s disease: a multimethod approach
32 kB
anonymous
g02-brain-structure-in-preclinical-hd
04.08.26
A multicentre approach for the detection of patterns of impairment in Huntington’s Disease by using diffusion tensor imaging
32 kB
anonymous
g08-detection-of-patterns-of-impairmen...
04.08.26
Structural connectivity-based topography of the basal ganglia is altered in premanifest and early manifest Huntington’s Disease
32 kB
anonymous
g09-topography-basal-ganglia
04.08.26
Brain activation and functional connectivity in premanifest Huntington’s disease during states of intrinsic and phasic alertness
32 kB
anonymous
g14-brain-activation-functional-connec...
04.08.26
Switch of cerebral A1 adenosine receptor radioligand binding during phenoconversion of Huntington disease – a PET study
32 kB
anonymous
g15-switch-of-cerebral-a1-adenosine-re...
04.08.26
Abnormal responses to visual cortex activation in early stage Huntington Disease patients using 31P-NMR spectroscopy
32 kB
anonymous
g13-visual-cortex-activation-in-early-...
04.08.26
From premanifest to manifest Huntington’s disease: a two year follow up study with magnetic resonance spectroscopy at 7 Tesla
32 kB
anonymous
g12-from-premanifest-to-manifest
04.08.26
Correlation between relaxometry and diffusion tensor imaging in the globus pallidus of huntington disease patients
32 kB
anonymous
g10-correlation-relaxometry-and-diffus...
04.08.26
Tractography of the corpus callosum in Huntington Disease
32 kB
anonymous
g11-tractography-of-corpus-callosum
04.08.26
Does CAG repeat length modulate rates of brain atrophy in Huntington’s Disease?
32 kB
anonymous
g0x-cag-repeat-length-brain-atrophy
Verzeichnis enthält 16 Dokumente.
impressum
|
datenschutz
|
haftungsausschluss
|
nutzungsbedingungen